Please login to the form below
NHS test and trace system ‘still not good enough’ says health leader
Test and trace system falls short in latest figures
Spending by pharma on UK R&D increased last year
Data shows third annual increase in a row
Cancer research funding could be cut due to COVID-19 pandemic
Charity warns £150m could be lost per year
New cancer blood test proves more sensitive than current diagnostic methods
Test could be up to ten times more sensitive than standard methods
FDA pulls emergency OK for hydroxychloroquine in COVID-19
Data shows drug may reduce effectiveness of remdesivir
Sinovac reveals positive preliminary data for COVID-19 vaccine
Plans protocol application for phase 3 study
bluebird set for 2021 filing for sickle cell gene therapy LentiGlobin
Gene therapy was approved last year as Zynteglo for beta thalassaemia
After industry lobbying, UK agrees to top up Biomedical Catalyst
News of funding comes after 40% decline in biotech funding in 2019
COVID-19 round-up: medicines on trial
New drugs starting clinical testing in COVID-19 patients, plus clinical results and regulatory filings
Who's calling the shots in European healthcare?
Patients versus Pharma: industry too powerful, and too cosy with EMA, says Yannis Natsis
-
The shifting healthcare landscape -
The power of pharma businesses to drive social changeThe importance of CSR programmes
-
FDA gives green light to Merck/MSD’s antibiotic drug RecarbrioApproved for hospital-acquired/ventilator-associated bacterial pneumonia
-
Lundbeck axes staff in revamp of its R&D Company’s domestic workforce will bear the brunt of the cuts
-
Bayer, MSD file heart failure drug vericiguat in EU and JapanFiling for first-in-class drug sets up approvals for next year
-
AstraZeneca forges agreements for equal access to COVID-19 vaccineAgreements reached with CEPI, Gavi and Serum Institute of India
-
UCB buys epilepsy firm Engage Tx in $270m dealDeal includes experimental drug-device combination therapy Staccato Alprazolam
-
Four European nations form alliance to fast-track COVID-19 vaccineFrance, Germany, Italy and the Netherlands join forces to accelerate production
-
Pierre Fabre’s Braftovi gets EU okay for BRAF+ colorectal cancerDrug is first to be specifically approved for this type of cancer in the EU
-
NICE looks internally for new chief executive Deputy chief exec Gillian Leng is set to take the helm
-
Paris biocluster appoints Stéphane Roques as new chiefFormer general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment
-
Picker appoints new CEOChris Graham to focus on person-centred care
-
EFPIA appoints new director generalNathalie Moll takes up the role from April
-
IFPMA appoints director generalThomas Cueni brings expertise from Interpharma and EFPIA
Latest healthcare appointments
COVID-19 Updates and Daily News
Featured jobs
- Sinovac reveals positive preliminary data for COVID-19 vaccine
- How will the events and exhibitions industry change post-Coronavirus?
- Finalists 2020 - Communiqué Awards
- Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus
- Novo Nordisk gets another OK for oral GLP-1 drug Rybelsus
- The best work in healthcare communications shines at virtual Communiqué Awards
PMHub
Hamell
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...
Latest intelligence
- The search for treatments for Parkinson’s disease
- The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
- Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
- Ditch the Label – it’s just me....
- The impact of COVID-19 on clinical trials
- As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...
Quick links
Infographics
